维普期刊资源整合服务平台（V6.5）

21篇 您的检索式：作者名="Spratlin J"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Looking to the future: biomarkers in themanagement of pancreatic adenocarcinoma 显示文摘	Spratlin J L Mulder K E	2011	International journalof molecular sciences2011，12，9：	1
2	Ramucirumab(IMC-1121B):a novel attack on angiogenesis显示文摘	Spratlin J Mulder K Mackey J	2010	Future Oncol2010，6，7：	1
3	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenucarcinoma 显示文摘	Spratlin J Sangha R Darry Glubrecht D etal	2004	Clin Cancer Res2004，10，20：	1
4	Pharmacokinetics of paclitaxel metabolism显示文摘	Spratlin J Sawyer MB	2007	Crit Rev Oncol/Hematol2007，61，3：	1
5	Pharmacogenetics of paclitaxel metabolism 显示文摘	Spratlin J Sawyer MB	2007	Crit Rev Oncol Hematol2007，61，3：	1
6	Looking to the future:biomarkers in themanagement of pancreatic adenocarcinoma显示文摘	Spratlin J L Mulder K E	2011	Int J Mol Sci2011，12，9：	1
7	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma显示文摘	Spratlin J Sangha R Glubrecht D	2004	Clin Cancer Res2004，10，20：	1
8	Community compliance with carcinoembryonic antigen: follow-up of patients with colorectal cancer 显示文摘	Spratlin JL Hui D Hanson J	2008	Clin Colorectal Cancer2008，7，3：	1
9	Pharmacogenetics of paclitaxelmetabolism显示文摘	Spratlin J Sawyer MB	2007	Crit Rev Oncol Hematol2007，61，3：	1
10	Beneficial effects of supplemental buffer and substrate on energy metabolism during small bowel storage显示文摘	Salehi P Spratlin J Chong TF	2004	Cryobiology2004，48，3：	1
11	The absence of human equilibrative nucleoside transporterl is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma显示文摘	Spratlin J Sangha R Glubrecht D	2004	Clin Cancer Res2004，10，20：	1
12	Pharmacogenetics of paclitaxel metabolism显示文摘	SPRATLIN J SAWYER M B	2007	Crit Rev Oncol/He- matol2007，61，：	1
13	Clinical applications of metabolomics in oncology: a review显示文摘	Spratlin JL Serkova N J Eckhardt SG	2009	Clin Cancer Res2009，15，2：	1
14	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma显示文摘	SPRATLIN J SANGHA R GLUBRECHT D	2004	Clin Cancer Res2004，10，20：	1
15	Community compliance with eareinoembryonie antigen: follow-up of patients with eoloreetal cancer 显示文摘	Spratlin JL Hui D Hanson J	2008	Clin Coloreetal Cancer2008，7，2：	1
16	How prognostic and predictive biomarkers are transforming our understanding and management of advanced gastric cancer显示文摘	Kim C Mulder K Spratlin J	2014	Oncologist2014，19，10：	1
17	The Absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma 显示文摘	Spratlin J Sangha R Glubrecht D	2004	Clin Cancer Res2004，10，20：	1
18	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma显示文摘	Spratlin J Sangha R Glubrecht D	2004	Clin Cancer Res2004，10，20：	1
19	The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma 显示文摘	Spratlin J Sangha R Glubrecht D	2004	Clin Cancer Res2004，10，20：	1
20	A Phase I study to assess the safety, tolerability,and pharmacokinetics of AZD4877,an intravenous Eg5 inhibitor in patients with advanced solid tumors显示文摘	Infante JR Kurzrock R Spratlin J	2012	Cancer Chemother Pharmacol2012，69，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示